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Macrosiphonia velame (Apocynaceae), popularly known as “velame-branco”, is mainly used for 
treating inflammatory conditions. The antiinflammatory, antinociceptive and antipyretic effects of the 
hydroethanolic extract of the xylopodium from M. velame (HEMv) were evaluated using several animal 
models. HEMv showed low acute oral toxicity with LD50 of 4.176 ± 218.5 mg/kg in mice. In tests of 
carrageenan and dextran-induced paw edema and carrageenan-induced pleurisy in rats, and croton oil-
induced cutaneous dermatitis in mice, HEMv presented systemic and topical antiinflammatory activities. In 
experiments of nociception induced by acetic acid, formalin and capsaicin in mice, the HEMv evidenced 
an antinociceptive effect, being active against both inflammatory and neurogenic pain. Additionally, the 
HEMv prevented brewer’s yeast-induced pyrexia in rats. It is likely that the pharmacologic mechanism of 
HEMv may involve the inhibition of different mediators of the inflammatory response, such as histamine, 
serotonin, prostaglandins and leukotrienes. A preliminary phytochemical study was also undertaken 
on HEMv, which revealed the presence of flavonoids, phenolic compounds, pentacyclic triterpenoids, 
saponins, coumarins, catechins, tannins, and alkaloids. Taken together, these results suggest that M. 
velame extract has antiinflammatory, antinociceptive and antipyretic properties and further validate the 
traditional use of this plant in inflammatory conditions. 
Uniterms: Macrosiphonia velame/antiinflammatory effect. Macrosiphonia velame/antinociceptive effect. 
Macrosiphonia velame/antipyretic effect. Macrosiphonia velame/pharmacognosy/experimentel study.
Macrosiphonia velame (Apocynaceae), conhecida popularmente como velame-branco, é utilizada 
no tratamento de inflamações. Avaliou-se nesse estudo, os efeitos antiinflamatório, antinociceptivo e 
antipirético do extrato hidroetanólico do xilopódio de M. velame (HEMv) em modelos animais. O HEMv 
apresentou baixa toxicidade aguda oral, com DL50= 4.176 ± 218,5 mg/kg nos camundongos. Nos testes 
de edema de pata por carragenina e dextrana e pleurisia por carragenina em ratos e dermatite cutânea 
por óleo de croton em camundongos, o HEMv apresentou atividade antiinflamatória sistêmica e tópica. 
Nos experimentos de nocicepção induzida por ácido acético, formalina e capsaicina em camundongos, 
o HEMv inibiu a resposta nociceptiva nos três modelos, mostrando-se ativo tanto na dor de origem 
inflamatória como neurogênica. Adicionalmente, o HEMv bloqueou a hipertermia induzida por levedura 
de cerveja nos ratos. É provável que os efeitos farmacológicos observados para o HEMv decorram da 
inibição de mediadores da resposta inflamatória produzidos pelas vias da COX e/ou LOX bem como da 
inibição da liberação de histamina e serotonina. A análise fitoquímica do HEMv revelou a presença de 
flavonóides, compostos fenólicos, triterpenóides pentacíclicos, saponinas, cumarinas, catequinas, taninos 
catéquicos e alcalóides. Estes resultados validam sob o ponto de vista pré-clínico, o uso popular de M. 
velame em processos inflamatórios.
Unitermos: Macrosiphonia velame/efeito antiinflamatório. Macrosiphonia velame/efeito antinociceptivo. 
Macrosiphonia velame/efeito antipirético/Macrosiphonia velame/farmacognosia/estudo experimental.
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INTRODUCTION
Macrosiphonia velame (A. St.-Hil.) M. Arg., po-
pularly known as “velame-branco”, “velame do campo” 
or “losna do campo”, is one of the most used plants as a 
medicinal resource by rural populations of central Brazil 
plateau (Guarim-Neto, Morais, 2003).
In interviews carried out with 15 herbal sellers from 
Goiania-Goias State, Brazil, M. velame was cited by 90% 
of respondents as an effective anti-inflammatory, depura-
tive and antisyphilitic agent (Santos et al., 2004). In Mato 
Grosso, home preparations made with “velame-branco” 
are used for different purposes, especially as a treatment 
for inflammation, skin diseases and as a blood depurative 
(Macedo, Ferreira, 2004; De La Cruz, 2008).
M. velame occurs naturally in soils with gravel cover 
in areas of Brazilian cerrado. The collection of this plant 
in an indiscriminate manner coupled with habitat loss due 
to intensive agriculture, have made this plant rare in the 
region. In spite of its high usage and risk of extinction, 
no chemical or pharmacological studies on the plant are 
available in the literature. Therefore, the aim of the present 
study was to investigate the anti-inflammatory, antinoci-
ceptive and antipyretic effects of hydroethanolic extract of 
the xylopodium of M. velame using experimental animal 
models.
MATERIAL AND METHODS
Plant material and extraction
The xylopodium of M. velame was collected in 
2007 in Acorizal, Mato Grosso State, Brazil (GPS coor-
dinates: S15° 04´17.3 W56°20´55.5) and taxonomically 
identified by Dr Rosilene Rodrigues Silva, a researcher 
from the Herbarium of the Federal University of Mato 
Grosso (UFMT). The voucher specimen has been preser-
ved at the UFMT Herbarium under the reference number 
38.289. The collection was authorized by the Brazilian 
Institute of Environment and Renewable Natural Re-
sources (IBAMA).
1 kg of xylopodium was, cleaned and dried under 
shade for 7 days at room temperature and shredded in 
an electric mill (sieve with a mesh size of 5 mm) until 
powder was obtained. Water-ethanol 75% (1:3 w/v) was 
added to the powder, which was macerated for 7 days, 
concentrated in a rotary evaporator under reduced pressure 
(600 mmHg), at a temperature of 50ºC, with the residual 
solvent being eliminated in an oven at 40º C, obtaining 
60.1 g (yield 6%) of hydroethanolic extract 75% from 
Macrosiphonia velame (HEMv).
Animals
Male Wistar rats and male Swiss-albino mice, sup-
plied by the UFMT Animal House, were used in the experi-
ments. The animals were grouped and housed in propylene 
cages, receiving a standard dry pellet diet (Purina®, Labina) 
and water ad libitum, under controlled temperature condi-
tions (22±2 °C) and a 12 h light-dark cycle. For the assays, 
animals were randomly assigned into groups of 6-8, except 
for the hippocratic and LD50 tests. Prior to the experiments, 
the animals were fasted for 18 h. The experimental protocols 
were previously approved by the Committee for Ethics in 
Animal Experimentation (CEPA/UFMT).
Preliminary phytochemical analysis
Phytochemical analysis  HEMv of was carried out based 
on color and precipitation tests, according to Matos (1988).
Acute toxicity assay
Three mice per group were used and treated orally 
(p.o.) with doses of 500 to 5,000 mg/kg of HEMv. A con-
trol animal was used for each dose, receiving vehicle only 
(10 mL/kg). All animals were individually observed in open 
field after the extract or vehicle was administered, at 0, 5, 
10, 15 and 30 min; 1, 2, 4 and 8 h and, once every day, for 
14 days. The results for the general behavioral observations 
were recorded in a table adapted from Malone (1977). To 
calculate the LD50 of the extract, HEMv at 3,000, 4,000, 
4,500 and 6,000 mg/kg doses were administered orally, in 
groups of 10 mice each (5 male and 5 female mice). After 
24 h, the number of dead animals was verified and LD50 was 
calculated according to Miller, Tainter (1944).
Rat paw edema induced by carrageenan and 
dextran
Rats (180-200g) were treated orally, with vehicle 
(10 mL/kg), HEMv (20 and 200 mg/kg) and indomethacin 
(10 mg/kg) in the carrageenan test, or vehicle, HEMv (50, 
200 and 800 mg/kg) and cyproheptadine (5 mg/kg) in the 
dextran test. After 1 h of treatment, the edema was induced 
by subplantar injection of 100 mL of lambda carrageenan 
(1% w/v in saline 0.9%) or dextran (1.5% w/v in saline 
0.9%) in the left posterior paw of the rats. The contralateral 
paw received the same volume of saline 0.9%. The volume 
of the edema of the paw was measured in a plestimograph 
(7150 model, Ugo Basile®) at 0, 60, 120, 180 and 240 min 
after injection of carrageenan or 0, 30, 60 and 120 min after 
injection of dextran (Winter et al., 1962).
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Carrageenan-induced pleurisy
Pleurisy was produced in rats (180-200 g) by the intra-
pleural injection of 0.1mL carrageenan at 2%. The animals 
received the vehicle, HEMv (50, 200 and 800 mg/kg) or 0.5 
mg/kg of dexamethasone orally, 1 h before the injection of 
the phlogistic agent. After 6 h, the animals were anestheti-
zed with ethyl ether, their thoracic cavities opened, pleural 
exsudate collected by aspiration, the volume measured (mL) 
and the total number of leukocytes quantified in a Neubauer 
hemocytometer (Vinegar et al., 1981).
Croton oil-induced cutaneous dermatitis
Mice (25-30 g) were used, topically treated in each 
ear with 20 µL of vehicle, HEMv (1, 10 and 100 µg) or 
dexamethasone (5 µg) incorporated in hostacerin® NCB 
formulation. After 6 h of the injection of the irritant subs-
tance, the animals were euthanized by cervical displa-
cement and both ears were extirpated at the base (6 mm 
diameter) and weighed on analytical laboratory scales 
(Swingle et al., 1981).
Acetic acid-induced writhing test
Mice (25-30 g) were treated orally with vehicle, 
HEMv (20 and 200 mg/kg) or indomethacin (5 mg/kg). 
After 1 h, 10 mL/kg of acetic acid 0.6% diluted in saline 
0.9% was injected intraperitoneally into each animal and 
the animal’s contortions (writhings) were counted during 
the subsequent 30 min (Koster et al., 1959).
Formalin test
Mice (25-30 g) received vehicle, HEMv (50, 200, 
800 mg/kg), indomethacin (10 mg/kg) or morphine (10 
mg/kg) orally. After 1 h, each animal received 20 µL for-
maldehyde solution 2.5% in saline 0.9% in the subplantar 
region of the left posterior paw. The time spent licking 
and / or biting the injected paw was timed during the first 
5 min (1st phase) and during the 20 – 30 min (2nd phase) 
interval which followed the injection of the noxic agent 
(Hunskaar et al., 1985).
Capsaicin test
Mice (25-30 g) were pre-treated orally 1 h before the 
test with vehicle and HEMv (50, 200 and 800 mg/kg), and 
with morphine 30 min before administration of the noxic 
agent. Animals subsequently received 20 µL capsaicin 
(1.6 µg/paw), injected into the subplantar region of the left 
posterior paw, and the time period the animal kept licking 
and / or biting the paw over the 5 min that followed was 
timed and recorded (Sakurada et al., 1992).
Brewer’s yeast induced pyrexia
Rats (160-180 g) received, subcutaneously, 5 mg 
of a 20% brewer’s yeast suspension in sterile saline 0.9% 
(w/v). After 21 h (zero time), the rectal temperature was 
monitored for 1 min using a clinical thermometer introdu-
ced 3 cm into the rectal ampoule. Subsequently, vehicle, 
HEMv (50, 200 and 800 mg/kg) or diclophenac sodium 
(30 mg/kg) were administered, and the rectal tempera-
ture taken again 1, 2 and 3 h after treatment. Another 
group received 5 mL/kg sterile saline 0.9%, instead of 
brewer’s yeast. After the recommended time, the vehicle 
was administered orally and rectal temperature was taken 
(Al-Ghamdi, 2001).
Rota-rod performance test
Male mice (25-30 g) were pre-selected 24 h in ad-
vance to eliminate those animals which could not stay on 
the bar for a period of 60 s. Animals were treated orally 
with vehicle, HEMv (50, 200 and 800 mg/kg) or intrape-
ritoneally with diazepam (5 mg/kg). The maximum period 
of time was 60 s, with up to 3 reintroductions to the rota-
rod (Letica LI 8200) were allowed (Rosland et al., 1990).
Statistical analysis
Results for the parametric tests were expressed as 
mean ± standard error of the mean (S.E.M.). Statistical sig-
nificance was determined by one-way analysis of variance 
(ANOVA), followed by Student-Newman–Keuls post-test, 
with p values <0.05 considered significant.
RESULTS
Preliminary phytochemical analysis
The preliminary phytochemical study carried out 
with HEMv showed the presence of alkaloids, catechins, 
phenolic compounds, coumarins, flavonoids, flavonones, 
saponins, condensed tannins and pentacyclic triterpenoids.
Acute toxicity test
Doses up to 1,000 mg/kg caused no behavioral 
alteration in the animals. Reduction in mobility and res-
piratory frequency was noted at 2,000 and 5,000 mg/kg 
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of HEMv, as well as mild analgesia (evidenced by tail 
compression), causing death of 2/3 of the animals at the 
highest dose, with LD50 = 4,176 ± 218.5 mg/kg, p.o. 
Carrageenan and dextran-induced paw edema
In the carrageenan-induced paw edema, animals 
which received the vehicle presented a slow edema evolu-
tion, reaching peak inflammatory response in the 3rd hour 
(0.60 ± 0.03 mL). The 20 and 200 mg/kg of HEMv reduced 
the paw edema in the 1st h (30 and 26.6%, p<0.01, respec-
tively), whereas only the lowest dose was active in the 3rd 
h, with 21.6% (p<0.01) edema inhibition. Indomethacin 
(10 mg/kg) was more active than HEMv, inhibiting edemas 
at all periods of time and reaching maximum effect in the 
3rd h (0.38 ± 0.03 mL, p<0.001) (Figure 1).
In the dextran-induced paw edema, rats treated with 
vehicle developed edema rapidly from the onset with inten-
sity, reaching its peak within 30 min (0.84 ± 0.8 mL). HEMv 
(200 and 800 mg/kg) reduced the edema by 26.2% and 29.8% 
(p<0.05), respectively, after 60 min of the phlogistic agent in-
jection. Cyproheptadine (5 mg/kg, p.o.) caused intense edema 
inhibition, starting from 30 min and maintaining inhibition up 
to the 2nd hour (54.3%, p <0.01) of the experiment (Figure 2).
Carrageenan-induced pleurisy
In the control group, the intrapleural injection of 
carrageenan 2% caused plasma leakage (1.74 ± 0.06 mL) 
and leukocyte infiltration (81.4 ± 1.8 x 106 cells).
HEMv (50, 200 and 800 mg/kg) reduced plasma 
exudation and cell migration, in a dose-dependent man-
ner, reaching its strongest effect with an 800 mg/kg dose 
(17.8% - p<0.01 and 40.3 % – p<0.001, respectively). De-
xamethasone (0.5 mg/kg) reduced both exudation (74.1%, 
p<0.001) and leukocyte infiltration (71.6%, p<0.001) more 
intensively than HEMv (Figure 3).
Croton oil-induced cutaneous dermatitis
The topical administration of 100 µg croton oil cau-
sed an increase of 6.07 ± 0.50 mg in the weight of control 
mice ears. The local treatment with HEMv (100 µg/ear) in 
hostacerin® NCB reduced ear edema by 50.4 % (p<0.05), 
whereas 5 µg dexamethasone reduced edema by 69.2% 
(p<0.01) (Figure 4).
Acetic acid-induced writhing in mice
The intraperitoneal injection of acetic acid (0.6%) 
caused strong nociceptive response in the control group, 
with 43.3 ± 2.8 abdominal contortions. Treating animals with 
HEMv (20 and 200 mg/kg) inhibited writhings caused by ace-
tic acid by 57 and 72% (p<0.001), respectively. Indomethacin 
(5mg/kg), the standard for this kind of experiment, reduced 
contortions by 91% (p<0.001) (Figure 5).
Formalin test
The injection of formalin (2.5%) coused in the control 
FIGURE 1 - Effect of oral treatment with vehicle (), hydroethanolic 
extract of M. velame (HEMv) at doses of 20 () and 200 mg/kg 
(), or 10 mg/kg of indomethacin (×), on carrageenan-induced 
paw edema in rats. Each value is the mean ± S.E.M. of 6-8 rats. 
*p<0.05, **p<0.01, ***p<0.001 compared with control. One-way 
ANOVA followed by Student-Newman–Keuls.
FIGURE 2 - Effect of oral treatment with vehicle (■), 
hydroethanolic extract of M. velame (HEMv) at doses of 
50 (▲), 200 (-) and 800 (+) mg/kg, or 5 mg/kg of cyproheptadine 
(×), on dextran-induced paw edema in rats. Each value is the 
mean ± S.E.M. of 7-8 rats. *p<0.05 and ***p<0.001 compared 
with control. One-way ANOVA followed by Student-
Newman–Keuls.
Antiinflammatory, antinociceptive and antipyretic effects of hydroethanolic extract from Macrosiphonia velame 519
FIGURE 3 - Effect of hydroethanolic extract of M. velame on exudate and cell migration carrageenan-induced in rats. Each value 
is the mean ± S.E.M. of 7-8 rats. *p<0.05, **p<0.01, ***p<0.001 compared with control. One-way ANOVA followed by Student-
Newman–Keuls.
FIGURE 4 - Effect of hydroethanolic extract of M. velame 
in hostacerin® on croton oil-induced cutaneous dermatitis 
in mice. Each value is the mean ± S.E.M. of 7-8 rats. 
*p<0.05 and **p<0.01 compared with control. One-way 
ANOVA followed by Student-Newman–Keuls.
FIGURE 5 - Effect of hydroethanolic extract of M. velame on 
acetic acid-induced writhing in mice. Values are expressed as 
mean ± S.E.M. (n = 7-8). One-way ANOVA followed by Student-
Newman–Keuls test. Significantly different to control, ***p<0.001.
group a characteristic biphasic response (Figure 6). The du-
ration of licking was 68.0 ± 2.6 s in the 1st phase (0-5 min) 
and 70.6 ± 4.9 s in the second phase (20-30 min). The results 
FIGURE 6 - Effect of hydroethanolic extract of M. velame on the 1st and 2nd phases of pain induced by formalin injection in mice. 
Each value is the mean ± S.E.M. of 8 rats. ***p<0.001 compared with control. One-way ANOVA followed by Student-Newman–
Keuls. 
show that, in the 1st phase, HEMv was active only at an 800 
mg/kg dose, reducing the nociceptive response by 54.7% 
(p<0.001), whereas in the 2nd phase HEMv was active for all 
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doses (50, 200 and 800 mg/kg), reaching its maximum effect 
at the highest dose (78%, p<0.001), exceeding even the 10 
mg/kg indomethacin effect (72.5%, p<0.001). Morphine (10 
mg/kg, p.o.) was shown to be equally effective in inhibiting 
the pain response, both in the 1st and 2nd phases, with 69.3 
and 67.7% (p<0.001) reductions, respectively.
Capsaicin test
The results presented in Figure 7 showed that HEMv 
(20, 200 and 800 mg/kg, p.o.) caused significant and dose-
dependent capsaicin-induced neurogenic pain inhibition. 
At the highest HEMv dose, responses reached a similar 
intensity (69.5%, p<0.001) to that obtained with 5 mg/kg 
morphine (75.1%, p<0.001), administered subcutaneously.
Brewer’s yeast-induced pyrexia
The subcutaneous injection of 20% brewer’s yeast 
suspension substantially increased the rectal temperature of 
the rats 21 h after administration (38.3 ± 0.13 °C vs. 37.1 ± 
0.16 °C, p<0.001). HEMv treatment at 200 and 800 mg/kg 
doses significantly reduced the rectal temperature of 
the animals in the 2nd and 3rd hours after administration, 
reaching peak antipyretic effect at the highest dose in the 
2nd hour (37.5 ± 0.08 °C, p<0.001) compared to controls 
(38.5 ± 0.01 °C). Diclophenac sodium treatment (30 mg/kg) 
caused significant reduction in rectal temperature at all 
periods of time, reaching peak antipyretic effect in the 2nd 
hour among all groups (37.0 ± 0.09, p<0.001), compared 
to control (38.3 ± 0.08 °C) (Figure 8).
 
Rota-rod performance test
Treating mice with HEMv (50, 200 and 800 mg/kg) 
presented no significant alterations (p>0.05) in motor 
coordination of the mice on the experimental spinning 
bar at any of the observed times, unlike the animals which 
received diazepam (5 mg/kg), whose time of permanence 
on the spinning bar was lower (33.4 ± 5.3 s, p<0.001) 
compared to the control group (60 ± 0 s).
DISCUSSION
With the aim of providing the first scientific evidence 
for the popular use of M. velame, the pharmacological 
effects of HEMv were investigated, particularly those 
related to the inflammatory process.
The carrageenan-induced paw edema model has 
frequently been used to evaluate the antiedematogenic 
effect of most anti-inflammatory drugs in routine clinical 
use (Carvalho et al., 1999). Reports describe that several 
mediators are released through the injection of carra-
geenan in the rat’s paw; while histamine, serotonin and 
bradykinin are released in the initial phase (0-1h), in the 
later phase (1-6 h) there is an increase in the production 
levels of prostaglandins (PGs) through the activation of 
cyclooxygenase-2 (COX-2) and release of nitric oxide 
(NO) (Silva et al., 2005).
In the carrageenan test, HEMv (20 and 200 mg/kg) 
exerted significant edema inhibition, albeit to a lesser 
degree than indomethacin (10 mg/kg), a non-selective 
COX-inhibitor that decreases PG production (Farsam et 
al., 2000).
It is known that histamine and serotonin are the 
principal inflammatory mediators involved in the dextran-
induced paw edema (Lo et al., 1982). HEMv caused sig-
nificant inhibition of dextran-induced edema, suggesting 
FIGURE 7 - Effect of hydroethanolic extract of M. velame on 
capsaicin induced nociception in mice. Each value is the mean ± 
S.E.M. of 7-8 rats. ***p<0.001 compared with control. One-way 
ANOVA followed by Student-Newman–Keuls.
FIGURE 8 - Effect of hydroethanolic extract of M. velame on 
brewer’s yeast induced pyrexia in rats. Each value is the mean 
± S.E.M. of 6-8 rats. *p<0.05, **p<0.01, ***p<0.001 compared 
with control or †††p<0.001 compared with yeast. One-way 
ANOVA followed by Student-Newman–Keuls.
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that it could interfere with either the degranulation of 
mast cells, and the consequent release of histamine and 
serotonin, or with their receptor actions.
Pleurisy and paw edema induced by carrageenan 
are considered the most appropriate experimental models 
for evaluating anti-inflammatory substances (Otterness, 
Gans, 1988). Leukocyte migration to the inflammation site 
is a key event in the inflammatory process. The injection 
of carrageenan in the pleural cavity of rodents causes an 
acute inflammatory response, characterized by accumula-
tion of fluids, and a large number of polymorphonuclear 
leukocytes (PML) in the pleural cavity. This causes lipid 
peroxidation and increased production of PGs, leukotrie-
nes, reactive oxygen species and cytokines such as TNF-α 
and IL1-β (Di Paola et al., 2004). Our results suggest 
that the plant extract may impact the production of these 
mediators thereby exerting an anti-inflammatory effect in 
this pleurisy model.
Croton oil is an irritant agent that induces an in-
flammatory response when applied to the ear skin through 
activation of phospholipase A2 and by initiation of arachi-
donate metabolism. The released arachidonic acid in turn 
is metabolized by COX and LOX enzymes promoting the 
production of eicosanoids and leukotrienes. As a conse-
quence, there is an increase in vascular permeability and 
hydrostatic pressure, resulting in edema formation and 
migration of neutrophils to the damaged area. The ear 
edema reaches its peak in the 6th hour, as a result of the 
formation of the arachidonic acid metabolites and other 
pro-inflammatory mediators (Swingle et al., 1981). This 
experimental model is used to detect COX and or LOX in 
vivo inhibition activity, being very sensitive to steroidal 
antiinflammatory drugs (SAIDs) and less sensitive to 
NSAIDs (Swingle et al., 1981; Young et al., 1984). In this 
model, topical application of HEMv (100 µg) produced a 
significant antiedematogenic effect, similar in intensity to 
the result observed with 5 µg dexamethasone. Although 
the present study established the efficacy of HEMv as an 
anti-inflammatory agent, its exact mechanism and the 
mediators involved have yet to be elucidated. 
Besides antiinflammatory activity, HEMv demons-
trated antinociceptive properties in the experimental 
models of nociception induced by acetic acid, formalin 
and capsaicin.
The abdominal contortions test induced by acetic 
acid – a visceral pain model – despite its high sensitivity 
and low specificity, is described as a typical model to re-
lieve inflammatory pain (Braggio et al., 2002). The local 
irritation caused by intraperitoneal administration of this 
agent, unleashes the release of several mediators, such 
as bradykinin, substance P and PGs, as well as cytokines 
such as IL-1β, TNF-α and IL-8. These mediators activate 
chemosensitive nociceptors which contribute to the de-
velopment of inflammatory pain. HEMv (20 and 200 mg/
kg) inhibited the mice nociceptive response to acetic acid 
in a significant and dose-dependent manner, suggesting 
suppression of inflammatory pain through the inhibition 
of release/activity of inflammatory mediators (Sekiya, 
Okuda, 1982).
The formalin test is more specific and frequently used 
in the study of nociception. The injection of formalin pro-
duces a particular biphasic response: the 1st phase involves 
the release of glutamate excitatory amino acid and sensorial 
neuropeptides, such as the substance P released from spinal 
cord sensorial neurons, whereas the 2nd phase depends ba-
sically on the liberation of inflammatory mediators and on 
functional changes in the spinal cord dorsal horn (Otuki et 
al., 2001). The HEMv blocked the licking response in both 
phases (the first phase response at the highest dose and 2nd 
phase at all doses), indicating that the extract is also effective 
against formalin-induced nociception.
Previous studies have shown that capsaicin indu-
ces the release of neurokinins, neuropeptides, excitatory 
amino acids (glutamate and aspartate), NO and pro-
inflammatory peripheral mediators, besides promoting the 
transmission of nociceptive information to the spinal cord 
and the activation of vanilloid receptors (Caterina, Julius 
2001). The inhibition of capsaicin-induced nociception 
suggests that HEMv may possibly interfere with the release 
of neuropeptides or their receptor activation.
The possibility of the HEMv antinociceptive effect 
being the result of motor deficits or CNS depression can 
be ruled out since the extract did not impair the animals’ 
motor performance on the rota-rod apparatus. 
These results The results in nociceptive tests indicate 
that HEMv has antinociceptive potential but does not de-
fine the exact mechanism, and further does not delineate 
whether its action is central or peripherally mediated. 
The brewer’s yeast-induced pyrexia test is of great 
relevance, as most NSAIDs inhibit the hyperthermal 
response. The injection of 20% brewer’s yeast causes 
release of pro-inflammatory cytokines which, upon rea-
ching circulation, stimulate the synthesis of PGE2 in the 
surroundings of the hypothalamic thermoregulator centers 
(Chan, Fiscus, 2004). HEMv (200 and 800 mg/kg) reduces 
the yeast-induced hyperthermia.
HEMv does not appear to cause any kind of acute 
toxicity when administered through orogastric gavage in 
the pharmacological assays, presenting a high LD50 (4,176 
± 218.5 mg/kg, p.o.), suggesting low oral toxicity.
The preliminary phytochemical studies with HEMv 
revealed the presence of alkaloids, catechins, phenolic 
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compounds, coumarins, flavonoids, saponins, condensed 
tannins and pentacyclic triterpenoids, having been pre-
viously described for its many pharmacological effects, 
including antiinflammatory, antinociceptive and antipyre-
tic activities (Safayhi, Sailer et al., 1997; Silva et al., 2002, 
Tuñón et al., 2009).
Although the exact nature of the antiinflammatory, 
antinociceptive and antipyretic activity mechanisms 
of the phytoconstituents have not been elucidated, the 
results of the present study validate from a pre-clinical 
point-of-view, the popular use of this medicinal plant in 
the treatment of inflammatory diseases.
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